The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early detection of side effects in patients with metastatic melanoma receiving immune checkpoint inhibitors by investigation of CD8+ immune infiltrate with [89Zr] crefmirlimab berdoxam PET.
 
Teresa Amaral
Consulting or Advisory Role - CeCaVa; Delcath Systems; NeraCare GmbH; Novartis; Pierre Fabre
Research Funding - Agenus (Inst); AstraZeneca (Inst); BioNTech SE (Inst); Biotech IOB (Inst); BMS GmbH & Co. KG (Inst); HUYA Bioscience International (Inst); Immunocore (Inst); MSD (Inst); NeraCare GmbH (Inst); Novartis (Inst); Pfizer (Inst); Philogen (Inst); Regeneron (Inst); Replimune (Inst); Roche/Genentech (Inst); Sanofi Aventis GmbH (Inst); Skyline Diagnostics (Inst)
 
Manfred Kneilling
No Relationships to Disclose
 
Andrea Forschner
Honoraria - BMS Brazil; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - BMS Brazil (Inst); Immunocore (Inst); MSD (Inst); Novartis (Inst); Pierre Fabre (Inst)
Research Funding - Bristol-Myers Squibb Stiftung Immunonkologie (Inst)
Travel, Accommodations, Expenses - Novartis; Pierre Fabre
 
Ulrike M. Leiter
Honoraria - Almirall Hermal GmbH; MSD; Novartis; Sanofi; Sun Pharma
Consulting or Advisory Role - Almirall Hermal GmbH; MSD; Novartis; Sanofi; Sun Pharma
Research Funding - MSD (Inst)
Travel, Accommodations, Expenses - Pierre Fabre; Sun Pharma
 
Johannes Schwenck
No Relationships to Disclose
 
Gabriele Kienzle
No Relationships to Disclose
 
Brigitte Gückel
No Relationships to Disclose
 
Dominik Sonanini
No Relationships to Disclose
 
Gerald Reischl
No Relationships to Disclose
 
Ian Wilson
Employment - ImaginAb
Leadership - ImaginAb
Patents, Royalties, Other Intellectual Property - patens in the field of imaging and radiotherapy
 
Bernd J. Pichler
Stock and Other Ownership Interests - BioNTech
Research Funding - Boehringer Ingelheim (Inst); Bruker (Inst); ImaginAb (Inst)
Patents, Royalties, Other Intellectual Property - Nanobody Patents; Senescence Patents
(OPTIONAL) Uncompensated Relationships - ImaginAb (Inst)
 
Christian la Fougère
Honoraria - AAA Canada; Bayer; Novartis
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Novartis
Research Funding - Siemens Heathineers (Inst)
 
Lukas Flatz
Stock and Other Ownership Interests - Hookipa Pharma
Consulting or Advisory Role - Philogen
Research Funding - Hookipa Pharma; Mundipharma
Patents, Royalties, Other Intellectual Property - Hookipa Pharma
Travel, Accommodations, Expenses - Hookipa Pharma